SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-055390
Filing Date
2020-10-20
Accepted
2020-10-20 17:16:43
Documents
2
Period of Report
2020-10-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 10719
2 POA DOCUMENT poa.txt EX-24.3_942031 2542
  Complete submission text file 0001209191-20-055390.txt   14868
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Issuer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REGULUS THERAPEUTICS INC. 3545 JOHN HOPKINS COURT, SUITE 210 SAN DIEGO CA 92121
Business Address
Szekeres David Leslie (Reporting) CIK: 0001602459 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33221 | Film No.: 201248898